Business Context and Reporting Period
Company: Medtronic Plc (formerly Medtronic, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: June 4, 2015
Subject: Dismissal of shareholder derivative actions (Item 8.01 Other Events).
Financial Metrics
This filing is a legal event report and does not contain financial statements. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing reports the final resolution of three shareholder derivative lawsuits filed between 2012 and 2014 in Minnesota state court. Plaintiffs voluntarily dismissed their claims with prejudice. The court signed orders dismissing the cases on May 27, 2015, and June 4, 2015.
Outlook, Risks, and Management Commentary
- Background: Lawsuits alleged a scheme to evade FDA prohibitions on off-label promotion of the product INFUSE and conspiracy to underreport adverse events.
- Investigation: A Special Litigation Committee (SLC) conducted an 18-month independent investigation.
- SLC Conclusion: The SLC determined the claims were without merit and that pursuing them was not in the Company's best interest.
- Outcome: All three actions (Himmel v. Ellis, Road Carriers v. Anderson, and Cutler v. Ishrak) were dismissed with prejudice, concluding the litigation.
Key Facts for Investor Verification
- Three derivative lawsuits regarding INFUSE promotion and adverse event reporting have been fully dismissed with prejudice.
- The Special Litigation Committee concluded the allegations against directors and officers were without merit.
- No financial penalties or settlements are mentioned in this specific filing.
- The dismissal orders were finalized between May 27, 2015, and June 4, 2015.